A Trial Comparing Risperidone Long-Acting Injection With Oral Antipsychotic in the Treatment of Early Psychosis

Clinical trial NCT00246259 · COMPLETED

Trial details

NCT number: NCT00246259
Sponsor: Janssen-Ortho Inc., Canada
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Schizophrenia Schizoaffective Disorder Schizophreniform Disorder Psychotic Disorders

Start date: 2004-10-01
Primary completion: 2008-12-01
Enrollment: 77

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.